N-Terminal bromodomain of Human BRD2 with I-BET726 (GSK1324726A)

4-[(2S,4R)-1-acetyl-4-[(4-chlorophenyl)amino]-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl]benzoic acid

The Discovery of I-Bet726 (Gsk1324726A), a Potent Tetrahydroquinoline Apoa1 Up-Regulator and Selective Bet Bromodomain Inhibitor.

N-TERMINAL BROMODOMAIN, UNP RESIDUES 67-200

O27.1.1, REALLY INTERESTING NEW GENE 3 PROTEIN, HUMAN BRD2

N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1,3- DIMETHYL-2-OXO-2,3-DIHYDRO-1H-1,3-BENZODIAZOLE-5- CARBOXAMIDE

BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-DIMETHYL-2- OXO-6-(PIPERIDIN-1-YL)-2,3-DIHYDRO-1H-1,3- BENZODIAZOL-5-YL-2-METHOXYBENZAMIDE

N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-((2R,4S )-2-METHYL-4-(PHENYLAMINO)-6-(4-(PIPERIDIN-1-YLMETHYL )PHENYL)-3,4-DIHYDROQUINOLIN-1(2H)-YL)ETHANONE

HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.

TRANSCRIPTION, INHIBITOR, HISTONE, EPIGENETIC READER, BET, BRD2, BROMODOMAIN